Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes

Nature

Volumn 432, Issue 7020, 2004, Pages 1027-1032

  Wolfrum, Christian ^a   Asilmaz, Esra ^a   Luca, Edilra ^a   Friedman, Jeffrey M ^a   Stoffel, Markus ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; FATTY ACIDS; GENES; GLUCOSE; INSULIN; LIPIDS; OXIDATION;

GLYCOLYSIS; KETOGENESIS; PLASMA INSULIN INHIBITS; STARVATION;

METABOLISM;

GLUCAGON; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

DIABETES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KETOGENESIS; LIPID METABOLISM; LIPID STORAGE; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS EXPRESSION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; DIABETES MELLITUS; DNA-BINDING PROTEINS; FASTING; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; KETONE BODIES; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MICE, OBESE; MITOCHONDRIA; NUCLEAR PROTEINS; OXIDATION-REDUCTION; PHOSPHORYLATION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 11144244418     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03047     Document Type: Article

References (30)

1. Wolfrum, C., Besser, D., Luca, E. & Stoffel, M. Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl Acad. Sci. USA 100, 11624-11629 (2003).
2. Barthel, A. & Schmoll, D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 285, E685-E692 (2003).
3. Laffel, L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 15, 412-426 (1999).
4. Casteels, K. & Mathieu, C. Diabetic ketoacidosis. Rev Endocr. Metab. Disord. 4, 159-166 (2003).
5. Lewis, G. E, Carpentier, A., Adeli, K. & Giacca, A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23, 201-229 (2002).
6. McGarry, J. D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7-18 (2002).
7. Nakae, J., Kitamura, T., Silver, D. L. & Accili, D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359-1367 (2001).
8. Franke, T. E, Kaplan, D. R., Cantley, L. C. & Toker, A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4- bisphosphate. Science 275, 665-668 (1997).
9. Altomonte, J. at al. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 285, E718-E728 (2003).
10. Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1a interaction. Nature 423, 550-555 (2003).
11. Shimomura, I. et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized hpodystrophy. Genes Dev. 12, 3182-3194 (1998).
12. Shimomura, I. et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77-86 (2000).
13. Freneaux, E. et al. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 8, 1056-1062 (1988).
14. Weinstein, D. C. et al. The winged-helix transcription factor HNF-3β is required for notochord development in the mouse embryo. Cell 78, 575-588 (1994).
15. Yoon, J. C. et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131-138 (2001).
16. Herzig, S. et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183 (2001).
17. Matsuda, T., Noguchi, T., Yamada, K., Takenaka,M. & Tanaka, T. Regulation of the gene expression of glucokinase and L-type pyruvate kinase in primary cultures of rat hepatocytes by hormones and carbohydrates. J. Biochem. (Tokyo) 108, 778-784 (1990).
18. Vaulont, S. & Kahn, A. Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J. 8, 28-35 (1994).
19. Chavin, K. D. et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 274, 5692-5700 (1999).
20. An, J. et al. Hepatic expression of malonyl-Coa expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nature Med. 10, 268-274 (2004).
21. Voshol, P. J. et al. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology 144, 3456-3462 (2003).
22. Stoffel, M. & Duncan, S. A. The maturity-onset diabetes of the young (MODY 1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc. Natl. Acad. Sci. USA 94, 13209-13214 (1997).
23. Louet, J. F., Hayhurst, G., Gonzalez, F. J., Girard, J. & Decaux, J. F. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression bit cAMP in combination with HNF4α and cAMP-response element-binding protein (CREB). J. Biol. Chem. 277, 37991-38000 (2002).
24. Kim, H. I. & Ahn, Y. H. Role of peroxisome proliferator-activated receptor-γ in the glucose-sensing apparatus of liver and β-cells. Diabetes 53 (Suppl. 1), S60-S65 (2004).
25. Stuempfle, K. J., Koptides, M., Karinch, A. M. & Floros, J. Preparation of transcriptionally active nuclear extracts from mammalian tissues. BioTechniques 21, 48-50, 52 (1996).
26. Unterman, T. G. et al. Hepatocyte nuclear factor-3 (HNF-3) binds to the insulin response sequence in the IGF binding protein-1 (IGFBP-1) promoter and enhances promoter function. Biochem. Biophys. Res. Commun. 203, 1835-1841 (1994).
27. Shih, D. Q. et al. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nature Genet. 27, 375-382 (2001).
28. Tobey, T. A., Mondon, C. E., Zavaroni, I. & Reaven, G. M. Mechanism of insulin resistance in fructosefed rats. Metabolism 31, 608-612 (1982).
29. Hoppel, C., DiMarco, J. P. & Tandler, B. Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J. Biol. Chem. 254, 4164-4170 (1979).
30. Lang, C. et al. Impaired hepatic fatty acid oxidation in rats with short-term cholestasis: characterization and mechanism. J. Lipid Res. 42, 22-30 (2001).